INBS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
INBS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Intelligent Bio Solutions's preferred dividends for the three months ended in Sep. 2024 was $0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.
The historical data trend for Intelligent Bio Solutions's Preferred Dividends can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intelligent Bio Solutions Annual Data | |||||||||||||||||
Trend | Jun17 | Jun18 | Jun19 | Jun20 | Jun21 | Jun22 | Jun23 | Jun24 | |||||||||
Preferred Dividends | Get a 7-Day Free Trial | - | - | - | - | - |
Intelligent Bio Solutions Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Preferred Dividends | Get a 7-Day Free Trial | - | - | - | - | - |
A dividend that is accrued and paid on a company's preferred shares.
Intelligent Bio Solutions (NAS:INBS) Preferred Dividends Explanation
In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.
Preferred Dividends for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Harry Simeonidis | director, officer: CEO, President | 708 THIRD AVENUE, 6TH FLOOR, NEW YORK CITY NY 10017 |
Foundation Ma-ran | 10 percent owner | 1908 CLIFF VALLEY WAY NE, ATLANTA GA 30329 |
Gary W. Rollins Foundation | 10 percent owner | 1908 CLIFF VALLEY WAY NE, ATLANTA GA 30329 |
David A Jenkins | director | P.O. BOX 682838, PARK CITY UT 84068 |
Jason Isenberg | director | 1908 CLIFF VALLEY WAY NE, ATLANTA GA 30329 |
Spiro Kevin Sakiris | officer: Chief Financial Officer | 708 THIRD AVENUE, 6TH FLOOR, NEW YORK CITY NY 10017 |
Life Science Biosensor Diagnostics Pty Ltd | 10 percent owner | LEVEL 9, 85 CASTLEREAGH STREET, SYDNEY C3 2000 |
Tom Parmakellis | director | 708 THIRD AVENUE, 6TH FLOOR, NEW YORK CITY NY 10017 |
Victoria Gavrilenko | director | 708 THIRD AVENUE,, 6TH FLOOR, NEW YORK CITY NY 10017 |
Christopher Towers | director | 1981 MARCUS AVENUE, SUITE 130, LAKE SUCCESS NY 11042 |
Lawrence B Fisher | director | C/0 FINANCIAL FEDERAL CORP, 733 THIRD AVENUE, NEW YORK NY 10017 |
Leonard Victor Kempler | director | 708 THIRD AVENUE,, 6TH FLOOR, NEW YORK CITY NY 10017 |
George Margelis | director | 708 THIRD AVENUE, 6TH FLOOR, NEW YORK CITY NY 10017 |
Boyages Steven Constantine | director | 708 THIRD AVENUE,, 6TH FLOOR, NEW YORK CITY NY 10017 |
Jonathan Scott Hurd | director | 708 THIRD AVENUE,, 6TH FLOOR, NEW YORK CITY NY 10017 |
From GuruFocus
By Marketwired • 11-13-2024
By Marketwired • 06-27-2024
By GuruFocus News • 11-15-2024
By Marketwired • 10-29-2024
By Marketwired • 11-21-2024
By Marketwired • 10-24-2024
By Marketwired • 11-26-2024
By Marketwired • 09-25-2024
By Marketwired • 09-19-2024
By Marketwired • 07-09-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.